QURE
Uniqure NV
Price:  
14.77 
USD
Volume:  
1,010,082.00
Netherlands | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QURE WACC - Weighted Average Cost of Capital

The WACC of Uniqure NV (QURE) is 10.4%.

The Cost of Equity of Uniqure NV (QURE) is 11.10%.
The Cost of Debt of Uniqure NV (QURE) is 9.50%.

Range Selected
Cost of equity 9.10% - 13.10% 11.10%
Tax rate 1.00% - 1.10% 1.05%
Cost of debt 7.00% - 12.00% 9.50%
WACC 8.3% - 12.6% 10.4%
WACC

QURE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.14 1.46
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 13.10%
Tax rate 1.00% 1.10%
Debt/Equity ratio 0.6 0.6
Cost of debt 7.00% 12.00%
After-tax WACC 8.3% 12.6%
Selected WACC 10.4%

QURE's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for QURE:

cost_of_equity (11.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.14) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.